Mind Medicine (MindMed) Inc.
MNMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $31 | $30 | $23 | $22 |
| G&A Expenses | $15 | $11 | $9 | $11 |
| SG&A Expenses | $15 | $11 | $9 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $46 | $41 | $32 | $32 |
| Operating Income | -$46 | -$41 | -$32 | -$32 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$22 | -$2 | $9 | -$2 |
| Pre-Tax Income | -$67 | -$43 | -$23 | -$35 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$67 | -$43 | -$23 | -$35 |
| % Margin | – | – | – | – |
| EPS | -0.78 | -0.5 | -0.27 | -0.41 |
| % Growth | -56% | -85.2% | 34.1% | – |
| EPS Diluted | -0.78 | -0.5 | -0.35 | -0.41 |
| Weighted Avg Shares Out | 86 | 85 | 85 | 84 |
| Weighted Avg Shares Out Dil | 86 | 85 | 87 | 84 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $3 | $2 | $3 |
| Interest Expense | $1 | $2 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$66 | -$40 | -$23 | -$34 |
| % Margin | – | – | – | – |